Electronic Decision Support for Intervention in Poorly Controlled Type 2 Diabetes

Completed · Not applicable · Has a placebo group

Conditions studied: Diabetes Mellitus

In brief

To determine the impact of an electronic decision support tool on physician decision making and patient outcomes for the treatment of poorly controlled diabetes mellitus. Primary endpoint will measure change in hemoglobin A1c. Secondary endpoints will examine cost of therapy and patient satisfaction with therapy. Study hypothesis is that use of the PATH decision tool will produce greater reduction overall in measurements of hemoglobin A1c in patients who participate and follow the PATH decision tool than patients who elect not to follow the PATH decision tool. PATH decision tool will provide more cost effective solutions for management of diabetic medication than current methods.

Key facts

Study ID
NCT02924207
Run by
St Elizabeth Healthcare
People needed
77
Starts
2016-09-01
Expected to finish
2018-12-01
Last updated by the study team
2019-10-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.